Diagnosis and Treatment of Intravascular Lymphomatosis
Authors:
- Nina HurwitzNHNina Hurwitz
- Eva Karamitopolou-DiamantisEKEva Karamitopolou-Diamantis
- Alfonse ProbstAPAlfonse Probst
- Richard HerrmannRHRichard Herrmann
- Andreas J. SteckASAndreas J. Steck
Open Access
- 1 March 2000
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 57 (3) , 374-377
Abstract
Objective To describe a patient with unusually good outcome of a rare, high-grade lymphoma that often involves the nervous system. Design Case report. Setting University hospital. Case A 70-year-old pharmacist first presented with meningoencephalitislike symptoms and 6 months later with acute confusional state followed by complex partial status epilepticus. Diagnosis of intravascular lymphomatosis was made using detection and biopsy of a bilateral adrenal tumor. Main Outcome and Results Polychemotherapy consisting of CHOP (cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone) led to complete remission. The patient's survival time currently exceeds 2½ years. Conclusions The possibility of intravascular lymphomatosis should be considered in adult patients with unclear meningoencephalitic syndrome, acute confusional state, dementia, or other unexplained neurologic conditions with signs of a systemic disease. In intravascular lymphomatosis, as in other high-grade non-Hodgkin lymphomas, CHOP polychemotherapy should be the standard treatment.Keywords
This publication has 6 references indexed in Scilit:
- Angiotropic lymphoma with endocrine involvementHistopathology, 1997
- Angiotropic large cell lymphoma presenting as primary adrenal insufficiencyHuman Pathology, 1996
- Four varied cases of intravascular lymphomatosis and a literature reviewCancer, 1994
- Intravascular lymphomatosis: a clinicopathological study of three casesJournal of Cancer Research and Clinical Oncology, 1994
- Intravascular malignant lymphomatosis: Amelioration of neurological symptoms with plasmapheresisAnnals of Neurology, 1994
- Further Evidence That Malignant Angioendotheliomatosis Is an Angiotropic Large-Cell LymphomaNew England Journal of Medicine, 1986